Dr. Holliday is a second-year radiation oncology resident, University of Texas MD Anderson Cancer Center, Houston, Texas. Dr. Jagsi is associate professor of radiation oncology and associate chair for faculty affairs, Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. Dr. Wilson is professor of therapeutic radiology and of dermatology; and vice chairman, clinical director, therapeutic radiology, Yale University School of Medicine, New Haven, Connecticut. Dr. Choi is a fifth-year radiation oncology resident, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois. Dr. Thomas is professor and chair of radiation medicine, Oregon Health & Science University Knight Cancer Institute, Portland, Oregon. Dr. Fuller is assistant professor of radiation oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, and has a joint faculty appointment, Department of Radiation Medicine, Oregon Health & Science University Knight Cancer Institute, Portland, Oregon.
Acad Med. 2014 May;89(5):767-73. doi: 10.1097/ACM.0000000000000229.
This study aimed to analyze gender differences in rank, career duration, publication productivity, and research funding among radiation oncologists at U.S. academic institutions.
For 82 domestic academic radiation oncology departments, the authors identified current faculty and recorded their academic rank, degree, and gender. The authors recorded bibliographic metrics for physician faculty from a commercially available database (Scopus, Elsevier BV), including numbers of publications from 1996 to 2012 and h-indices. The authors then concatenated these data with National Institutes of Health (NIH) funding per Research Portfolio Online Reporting Tools. The authors performed descriptive and correlative analyses, stratifying by gender and rank.
Of 1,031 faculty, 293 (28%) women and 738 (72%) men, men had a higher median m-index, 0.58 (range 0-3.23) versus 0.47 (0-2.5) (P < .05); h-index, 8 (0-59) versus 5 (0-39) (P < .05); and publication number, 26 (0-591) versus 13 (0-306) (P < .05). Men were more likely to be senior faculty and receive NIH funding. After stratifying for rank, these differences were largely nonsignificant. On multivariate analysis, there were correlations between gender, career duration and academic position, and h-index (P < .01).
Determinants of a successful career in academic medicine are multifactorial. Data from radiation oncologists show a systematic gender association, with fewer women achieving senior faculty rank. However, women achieving seniority have productivity metrics comparable to those of male counterparts. This suggests that early career development and mentorship of female faculty may narrow productivity disparities.
本研究旨在分析美国学术机构放射肿瘤学家的职称、职业年限、发表成果和研究经费方面的性别差异。
作者确定了 82 个国内学术放射肿瘤学系的现任教职员工,并记录了他们的学术职称、学位和性别。作者从商业数据库(爱思唯尔 Scopus)中记录了医师的文献计量指标,包括 1996 年至 2012 年的发表论文数量和 h 指数。作者随后将这些数据与美国国立卫生研究院(NIH)通过研究组合在线报告工具(Research Portfolio Online Reporting Tools)提供的经费进行了串联。作者对数据进行了描述性和相关性分析,按性别和职称进行了分层。
在 1031 名教职员工中,293 名为女性(28%),738 名为男性(72%),男性的中位 m 指数为 0.58(范围 0-3.23),高于女性的 0.47(范围 0-2.5)(P <.05);h 指数为 8(0-59),高于女性的 5(0-39)(P <.05);发表论文数为 26(0-591),高于女性的 13(0-306)(P <.05)。男性更有可能担任资深教职员工并获得 NIH 经费。按职称分层后,这些差异大多无统计学意义。多变量分析显示,性别、职业年限和学术地位与 h 指数之间存在相关性(P <.01)。
学术医学成功职业的决定因素是多方面的。放射肿瘤学家的数据显示,存在系统的性别关联,较少的女性能够达到资深教职员工的地位。然而,达到资深地位的女性的生产力指标与男性同行相当。这表明,对女性教职员工进行早期职业发展和指导可能会缩小生产力差距。